Expert Interview
Understanding utility of implantable infusion pumps and comparing Medtronic's SynchroMed 2 with Flowonix's Prometra 2
Ticker(s): MDT, NVRO, NVTRPain specialist who has experience with both Medtronic's SynchroMed 2 and Flowonix's Prometra 2. Physician should be able to speak to pros/cons of implantable infusion pump vs. spinal cord stimulation
Discuss the type of patient who can benefit from an implantable infusion pump
Added By: hc alphaDiscuss when you would use an implantable infusion pump vs. SCS
Added By: hc alphaPer every 10 patients, how many suffering from severe back-pain are potential infusion pump candidates?
Added By: hc alphaIs the therapy's reputation negative, neutral, or positive compared with five-years ago
Added By: hc alphaOver the next 5 years, would you expect fewer, the same, or more implantable infusion pump procedures
Added By: hc alphaDiscuss your view of the Prometra 2?
Added By: hc alphaCompare the Prometra 2 to the MDT SynchroMed 2?
Added By: hc alphaWhat are primary factors that would cause you to select one device vs. the other
Added By: hc alphaWhat percent of your implants are the Prometra 2 vs. the MDT
Added By: hc alphaWhat are primary concerns with Prometra 2?
Added By: hc alphaAre you comfortable with Conditional MRI labeling and/or do you drain the device prior to MRI?
Added By: hc alphaWhat improvements would you like to see on the device?
Added By: hc alphaHave you had any serious device issues?
Added By: hc alphaWhat competitive threats could take share from Prometra 2 or implantable pain pumps in general?
Added By: hc alphaAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
